1,940 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Acquired by Teza Capital Management LLC

Teza Capital Management LLC purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,940 shares of the medical equipment provider’s stock, valued at approximately $1,013,000.

A number of other large investors have also added to or reduced their stakes in the stock. Norges Bank bought a new stake in Intuitive Surgical during the fourth quarter worth $2,401,493,000. Proficio Capital Partners LLC lifted its stake in shares of Intuitive Surgical by 89,098.8% in the 4th quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock valued at $495,845,000 after acquiring an additional 948,902 shares during the last quarter. Capital Research Global Investors lifted its stake in shares of Intuitive Surgical by 25.5% in the 4th quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider’s stock valued at $1,764,904,000 after acquiring an additional 687,906 shares during the last quarter. Raymond James Financial Inc. bought a new position in Intuitive Surgical during the 4th quarter worth $313,769,000. Finally, Northern Trust Corp raised its position in Intuitive Surgical by 15.8% during the 4th quarter. Northern Trust Corp now owns 3,619,293 shares of the medical equipment provider’s stock worth $1,889,126,000 after purchasing an additional 494,496 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $563.60 on Monday. The stock has a market cap of $202.00 billion, a P/E ratio of 87.93, a PEG ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a fifty-two week low of $395.60 and a fifty-two week high of $616.00. The firm’s fifty day moving average price is $505.22 and its 200-day moving average price is $536.84.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.10. The firm had revenue of $2.25 billion for the quarter, compared to analysts’ expectations of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same quarter in the prior year, the firm posted $1.50 earnings per share. Sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Activity at Intuitive Surgical

In related news, EVP Myriam Curet sold 2,401 shares of the stock in a transaction on Thursday, February 27th. The stock was sold at an average price of $581.00, for a total value of $1,394,981.00. Following the transaction, the executive vice president now owns 353 shares of the company’s stock, valued at $205,093. This represents a 87.18% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Fredrik Widman sold 810 shares of the stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $573.78, for a total value of $464,761.80. Following the completion of the transaction, the vice president now directly owns 473 shares in the company, valued at approximately $271,397.94. This represents a 63.13% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 32,700 shares of company stock valued at $16,865,621 over the last 90 days. 0.70% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on ISRG shares. Leerink Partners raised their target price on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Erste Group Bank lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Monday, March 17th. Royal Bank of Canada decreased their target price on Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating for the company in a research report on Wednesday, April 23rd. UBS Group boosted their target price on Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research report on Monday, January 27th. Finally, Citigroup boosted their target price on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research report on Friday, January 24th. Five investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus price target of $598.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.